Induction of hyperacute graft-vs-host disease after donor leukocyte infusions

Archives of Dermatology

Volumn 135, Issue 3, 1999, Pages 304-308

  Fernández Herrera, Jesús ^a   Valks, Ruud ^a   Feal, Carlos ^a   Fraga, Javier ^a   Tomás, José F ^a   Garcia Díez, Amaro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; INJECTION SITE; LICHENOID; MALE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; TREATMENT INDICATION;

EID: 0345004130     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.3.304     Document Type: Article

References (21)

1. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324:667-674.
2. Kolb HJ, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462-2465.
3. Porter DL, Roth MS, McGarigle C, et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med. 1994; 330:100-106.
4. van Rhee F, Lin F, Cullis JO, et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood. 1994;83:3377-3383.
5. Drobyski WR, Keever CA, Roth MS, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 1993;82:2310-2318.
6. Hertenstein B, Wiesneth M, Novotny J, et al. Interferon-α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation. 1993;56:1114-1118.
7. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86:2041-2050.
8. Porter DL, Antin JH. Adoptive immunotherapy in bone marrow transplantation. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Gratt-vs-Host Disease. 2nd ed. New York, NY: Marcel Dekker Inc: 1996:733-754.
9. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-562.
10. Cullis JO, Jiang YZ, Schwarer AP, et al. Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation. Blood. 1992;79:1379-1381.
11. Barrett AP, Bilous AM. Oral patterns of acute and chronic graft-vs-host disease. Arch Dermatol. 1984;120:1461-1465.
12. Horn TD, Zahurak ML, Atkins D, Solomon AR, Vogelsang GB. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Arch Dermatol. 1997;133:961-965.
13. Sale GE, Beauchamp M. The parafollicular hair bulge in human GVHD: a stem cell rich primary target. Bone Marrow Transplant. 1993;11:223-225.
14. Aragüés MA, Fraga J, Fernández-Herrera JM, García-Díez A, Arranz R. Enfermedad injerto contra huésped cutánea: estudio clínico e histopatológico. Actas Dermosifiliogr. 1987;78:7-11.
15. Acevedo A, Aramburu J, López J, Fernández-Herrera J, Fernández-Rañada JM, López-Botet M. Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol. 1991;97: 659-666.
16. Sullivan K, Deeg HJ, Sanders A, et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood. 1986;67:1172-1175.
17. Orlow SJ, Friedman-Kien AE. Cutaneous ulcerations secondary to interferon alfa therapy of Kaposi's sarcoma. Arch Dermatol. 1992;128:566.
18. Oeda E, Shinohara K. Cutaneous necrosis caused by injection of α-interferon in a patient with chronic myelogenous leukemia. Am J Hematol. 1993;44:213-214.
19. Webster GF, Knobler RL, Lublin FD, et al. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol. 1996;34:365-367
20. Kernan NA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986;68:770-773.
21. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.